BSE Live
Jan 02, 16:01Prev. Close
179.75
Open Price
179.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:55Prev. Close
179.87
Open Price
179.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
182.19 (205)
| Balance Sheet of Marksans Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 40.93 | 38.53 | 38.53 | 36.78 | 36.78 | |
| Total Share Capital | 53.43 | 52.03 | 52.03 | 50.28 | 50.28 | |
| Reserves and Surplus | 326.33 | 90.15 | 34.45 | -219.51 | -115.40 | |
| Total Reserves and Surplus | 326.33 | 90.15 | 34.45 | -219.51 | -115.40 | |
| Total Shareholders Funds | 379.76 | 142.18 | 86.48 | -168.07 | -65.12 | |
| Minority Interest | 8.10 | 6.64 | 6.99 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 19.82 | 7.88 | 15.20 | 19.00 | |
| Deferred Tax Liabilities [Net] | 1.46 | 2.34 | 2.62 | 13.06 | 15.71 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 1.46 | 22.16 | 10.49 | 28.26 | 34.72 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 82.19 | 105.54 | 113.79 | 113.92 | 115.98 | |
| Trade Payables | 107.02 | 83.18 | 56.06 | 58.62 | 55.11 | |
| Other Current Liabilities | 39.88 | 96.58 | 108.73 | 336.39 | 341.76 | |
| Short Term Provisions | 57.15 | 33.82 | 18.70 | 13.62 | 6.93 | |
| Total Current Liabilities | 286.24 | 319.12 | 297.28 | 522.56 | 519.79 | |
| Total Capital And Liabilities | 675.55 | 490.10 | 401.24 | 388.36 | 491.89 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 102.37 | 72.48 | 74.13 | 73.87 | 73.73 | |
| Intangible Assets | 63.53 | 73.17 | 81.99 | 91.49 | 204.86 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 165.90 | 145.65 | 156.12 | 165.35 | 278.59 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.83 | 1.50 | 1.20 | 4.08 | 3.88 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 166.72 | 147.15 | 157.32 | 169.44 | 282.47 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 130.11 | 102.59 | 77.69 | 73.36 | 67.22 | |
| Trade Receivables | 183.45 | 169.61 | 131.31 | 112.77 | 98.86 | |
| Cash And Cash Equivalents | 185.27 | 46.95 | 15.88 | 22.39 | 30.92 | |
| Short Term Loans And Advances | 10.01 | 23.80 | 19.04 | 10.41 | 12.41 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Total Current Assets | 508.83 | 342.95 | 243.93 | 218.93 | 209.42 | |
| Total Assets | 675.55 | 490.10 | 401.24 | 388.36 | 491.89 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 55.63 | 83.81 | 237.03 | 0.33 | 0.00 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y